Meglu Tablet 850 mg contains Metformin Hydrochloride, a widely used oral antihyperglycemic agent for the management of type 2 diabetes mellitus. Belonging to the biguanide class, Metformin helps regulate blood sugar levels by improving the body’s insulin sensitivity and reducing hepatic glucose production.

Unlike other antidiabetic drugs, Metformin does not stimulate insulin secretion, which means it does not cause hypoglycemia when used as monotherapy. In addition to controlling blood glucose, Meglu Tablet 850 mg is associated with weight neutrality or modest weight reduction, making it especially suitable for overweight or obese individuals with type 2 diabetes.

This tablet formulation ensures convenient oral dosing, allowing patients to achieve effective long-term glycemic control while maintaining adherence to therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Meglu Tablet 850 mg is indicated for:

• Type 2 diabetes mellitus in adults and adolescents (10 years and older)

• Monotherapy in patients not adequately controlled by diet and exercise alone

• Combination therapy with other antidiabetic medications, including insulin, when monotherapy is insufficient

• Prevention of type 2 diabetes in high-risk individuals, under medical supervision

Meglu helps reduce fasting and postprandial blood sugar levels, supports metabolic health, and lowers the risk of long-term diabetes-related complications.

Dosage and Administration

Recommended dosage:

• Adults: Typically 850 mg once or twice daily, depending on glycemic response and physician guidance

• Maximum daily dose: 2,000–2,500 mg, divided into 2–3 doses if necessary

• Pediatric dosing: Based on weight and clinical response, as determined by a physician

Administration guidelines:

• Take tablets with meals to minimize gastrointestinal discomfort

• Swallow tablets whole; do not crush or chew

• Maintain a consistent daily schedule for optimal blood glucose control

• Regular monitoring of blood sugar levels is recommended to assess effectiveness

Precautions and Warnings

• Risk of lactic acidosis: Rare but serious; more likely in patients with renal impairment, liver disease, severe infection, or dehydration

• Renal function monitoring: Metformin is contraindicated in severe kidney impairment

• Hepatic caution: Use carefully in patients with liver dysfunction

• Contrast media: Temporarily discontinue before iodinated contrast imaging to reduce risk of renal complications

• Pregnancy and breastfeeding: Generally considered safe under medical supervision; consult a healthcare provider

• Alcohol: Excessive consumption may increase the risk of lactic acidosis

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Meglu Tablet 850 mg is generally well tolerated. Common side effects include:

• Gastrointestinal issues: nausea, vomiting, diarrhea, bloating, and abdominal discomfort

• Mild metallic taste

• Long-term use may rarely cause vitamin B12 deficiency

Serious reactions, such as lactic acidosis, are extremely rare but require immediate medical attention. Most side effects are transient and can be minimized by taking the tablet with food or adjusting the dose.

Storage

Store in a cool, dry place below 25°C, protected from light and moisture. Keep the tablets in their original packaging and out of reach of children.

Meglu Tablet 850 mg (Metformin Hydrochloride) is an effective first-line therapy for type 2 diabetes, providing glycemic control, metabolic benefits, and long-term cardiovascular protection. Its convenient oral formulation and once- or twice-daily dosing make it an ideal choice for managing blood sugar and improving overall health.